Alcohol and drug use among Durham Region Students infographic

| August 25, 2015

article image
Substance use before the age of 25 can lead to brain damage and long term problems because the brain is not fully developed until people are in their mid-twenties. Youth are at a high risk when drinking alcohol as they are more likely to drink large amounts at one time. Teens are watching what you do as a parent and your behaviour affects them. Think about your own opinions and substance use, and what messages they are sending to your teen.

Spotlight

W. L. Gore & Associates

Gore is a materials science company whose Associates are driven by curiosity and the opportunity to improve lives through our products and innovations. Working closely and collaboratively with our customers, we devise best-fit solutions that work the first time and every time delivering a high standard of reliability expected by our customers and the people they serve. With products ranging from medical devices that treat aneurysms to high-performance GORE-TEX® Fabrics, and with over 2,000 patents granted in our 60-year history, we’re committed to innovations that improve lives.

OTHER ARTICLES

Pharmacist eCare Plan - the newest disrupter in health data exchange?

Article | February 25, 2020

Every member of the health care team shares a common goal of optimizing patient outcomes. Yet each specialty and position of the healthcare team has a unique workflow facilitated by various tools, from an operative report to a progress note. In this regard the pharmacist plays a pivotal function in medication management and requires documentation specific to that role. The Pharmacist eCare Plan (PeCP) allows for an interoperable note to be used in the pharmacy to assist in the exchange of patient information, including active medication list, laboratory results, and payer information. To allow for this, a new type of clinical document architecture for the PeCP was created and standardized for use across pharmacies.

Read More

Clinical Supply Availability & Speed to Study Start-Up

Article | February 25, 2020

If you’re part of a clinical study team racing a new product to commercialization, you likely live by these two simple rules: time is money, and the first one to market wins. But just because it’s simple doesn’t mean it’s easy. That ticking clock is background noise to the responsibilities of regulations, study protocols, supply chains, and patient recruitment — all the details that must be worked out before a study can even begin. The pressure is always there. The longer it takes for a study to start, the longer it takes to complete.

Read More

What are the advantages of PCD Pharma Company?

Article | February 25, 2020

PCD Pharma stands for propaganda distribution. A PCD company gives brand name and support to its franchises. They also provide distribution rights and monopoly rights within a particular region. If a person wants to establish their business, it is a must for them to know the pros and cons of the business to make a sound decision. Needless to mention that PCD company has a lot to contribute in the medical filed. Worldwide in a medical field, A PCD Pharma Company is playing an essential and crucial role in the rapid growth. The pharma industry is progressing t a fast pace. The company uses the latest technologies for each brand which ensures the safety of products and accepts the responsibility of human health & life by providing better outcomes. To have a drug license number and company registration, the cost to establish the company is quite cost-effective that is15000-20000rs. So this gives people a brilliant opportunity to have their unit without digging a big hole in their bank balance. Indian produces exquisite quality products, which make pharma companies a considerable success.

Read More

Roche Prepares to Launch COVID-19 Antibody Test System

Article | February 25, 2020

Swiss pharma giant Roche is joining the race to develop a test for COVID-19 antibodies in people who have been exposed to the disease. This morning, Roche announced the development and upcoming launch of its Elecsys Anti-SARS-CoV-2 serology test to detect antibodies in people who have been exposed to the SARS-CoV-2, the virus that causes COVID-19. Roche is eying May for the launch of the test in Europe and is in talks with the U.S Food and Drug Administration for emergency approval of the system. Antibody testing is central to help identify people who have been infected by the virus, especially those who may have been infected but did not display symptoms, the company said. Roche noted that as more information becomes available about immunity levels to COVID-19, society can return to a sense of normal much more quickly. Roche’s test will join a number of other antibody tests that have recently come on the market. Earlier this month the U.S. Food and Drug Administration approved the first blood test for COVID-19 antibodies.

Read More

Spotlight

W. L. Gore & Associates

Gore is a materials science company whose Associates are driven by curiosity and the opportunity to improve lives through our products and innovations. Working closely and collaboratively with our customers, we devise best-fit solutions that work the first time and every time delivering a high standard of reliability expected by our customers and the people they serve. With products ranging from medical devices that treat aneurysms to high-performance GORE-TEX® Fabrics, and with over 2,000 patents granted in our 60-year history, we’re committed to innovations that improve lives.

Events